


























































































































































































































































































































Case  Year  Female  Male  Tested  True +  Neutered/Spayed  Euthanized 
1  2007  19  5  4  4  5  0 
2  2009  60  15  75  3  2  0 
3  2008  145  50  16  1  0  1 
4  2012  106  42  6  1  1  ? 
5  2012  40  7  31  13  0  13 





























































































































































































































































N/A  KDHE  Yes  N/A   
African Swine Fever  KDA‐DAH  N/A  N/A  Yes   
Amebiasis  N/A   KDHE  Yes  N/A   












USDA  KDHE  Yes  N/A   
Avian Influenza  KDA‐DAH   N/A  N/A  Yes   








Bovine Leukosis  KDA‐DAH  N/A  N/A  Yes   
Brucellosis  KDA‐DAH   KDHE  Yes  Yes   
Campylobacter 
Infections 
N/A  KDHE  Yes  No   
Chancroid  N/A  KDHE  Yes  N/A   
Chlamydia 
trachomatis 
N/A  KDHE  Yes  N/A   






Cryptosporidiosis  N/A  KDHE  Yes  N/A   
Cyclospora Infection  N/A  KDHE  Yes  N/A   
Diphtheria  N/A  KDHE  Yes  N/A   
Ehrlichiosis  N/A  KDHE  Yes  N/A   
Equine Infectious 
Anemia 












KDA‐DAH   N/A  N/A  Yes   
Fowl Typhoid  KDA‐DAH  N/A  N/A  Yes   
Giardiasis  N/A  KDHE  Yes  N/A   




N/A  KDHE  Yes  N/A   
Hantavirus 
Pulmonary Syndrome 
N/A  KDHE  Yes  N/A   
Hemolytic Uremic 
Syndrome, Post 










Hepatitis, Viral  N/A  KDHE  Yes  N/A   





N/A  KDHE  Yes  N/A   
Johne’s Disease  KDA‐DAH   N/A  N/A  Yes   
Legionellosis  N/A  KDHE  Yes  N/A   
Leprosy or Hansen’s 
disease 
N/A  KDHE  Yes  N/A   
Listeriosis  N/A  KDHE  Yes  N/A   
Lyme disease  N/A  KDHE  Yes  N/A   
Malaria  N/A  KDHE  Yes  N/A   




































Piroplasmosis  KDA‐DAH  N/A  N/A  Yes   
Plague or Yersinia 
pestis  












Pseudorabies  KDA‐DAH  N/A  N/A  Yes   
Psittacosis  KDA‐DAH  KDHE  Yes  Yes   
Psoroptic Mange  KDA‐DAH  N/A  N/A  Yes   
Pullorum  KDA‐DAH   N/A  N/A  Yes   
Q Fever (Coxiella 
burneti) 












Rinderpest  KDA‐DAH     N/A  Yes   
Rocky Mountain 
spotted fever 















N/A  KDHE  Yes  N/A  Isolates must be 
sent to DHEL 
Scabies  KDA‐DAH  N/A  N/A  Yes   













Shigellosis  N/A  KDHE  Yes  N/A  Isolates must be 
sent to DHEL 

















N/A  KDHE  Yes  N/A   






























Tularemia  N/A  KDHE  Yes  N/A   
Varicella or 
Chickenpox 
N/A  KDHE  Yes  N/A   
Vesicular Exanthema  KDA‐DAH  N/A  N/A  Yes   
Vesicular Stomatitis  KDA‐DAH   N/A  N/A  Yes   
Viral hemorrhagic 
fever 









KDA‐DAH   N/A  N/A  Yes   
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CASE DEFINITION  
Clinical Description for Surveillance: 
 An illness characterized by infertility or sudden abortion in canines. Other signs 
include one or more of the following: prolonged mucus discharge from the 
vagina, still births, epididymitis, unwillingness to mate, decreased ejaculate, or 
recurrent uveitis.  
Laboratory Criteria for Case Classification: 
 Definitive:            
o Culture and identification of B. canis from clinical specimens 
o Evidence of fourfold or greater rise in Brucella antibody titer between 
acute- and convalescent-phase serum specimens obtained greater than or 
equal to 2 weeks apart 
 Presumptive: 
o Positive reading using 2-mercaptoethanol Rapid Slide Agglutination Test 
(ME-RSAT), the Tube Agglutination Test (TAT), or the Indirect Fluorescent 
Antibody test (IFAT) with a 1:200 titer 
 
o Detection of Brucella DNA in a clinical specimen by polymerase chain 
reaction (PCR) assay 
Case Classification: 
 Confirmed: A clinically compatible illness with definitive laboratory evidence of 
Brucella Infection/ isolation of Brucella from a clinical specimen by culture 
 Probable: A clinically compatible case and elevated antibody serology to B. 
canis; or detection of B. canis nucleic acids in a clinical specimen by amplification 
of a specific target by polymerase chain reaction assay 





EPIDEMIOLOGY of Canine Brucellosis in Dogs 
Canine brucellosis is a zoonotic reproductive disease in dogs, and is not commonly 
reported in the United States. Many states do not list canine brucellosis as a reportable 
disease. Some believe the low prevalence of canine brucellosis in the U.S. can be 




B. canis is a Gram negative, non-motile, aerobic intracellular coccobacillus. Once 
in the environment it is susceptible to common household cleaning supplies and 
direct sunlight. 
 
B. Clinical Description: 
Signs include but are not limited to: epididymitis, testicular atrophy or orchitis, 
scrotal dermatitis, prostatitis, infertility, loss of libido, diskospondylitis, mucosal 
vaginal secretions, and sudden abortion or reabsorption. 
 
C. Reservoirs: 
B. canis has only been known to be acquired from dogs. 
 
D. Mode of Transmission: 
Transmission occurs through direct contact with infected animals’ fluids and/or 
tissues including: urine, vaginal discharges, aborted fetuses, placentas, and 
ocular fluids. Airborne transmission may occur through inhalation of aerosols in 
experimental settings.  
 
E. Incubation Period: 
Variable incubation period, ranging from 5-60 days but may be several months; 
illness most commonly occurs about 1 month after exposure. 
 
F. Period of Communicability: 
Animals may be infectious for years. 
 
G. Treatment: 
Antibiotic treatment is not recommended as the bacteria can be shed after 
treatment is complete. Euthanasia is recommended. 
 
H. Vaccine: 










1) Use current case definition, to confirm diagnosis with the veterinarian. 
2) Conduct a case investigation to identify potential sources of infection. 
3) Conduct contact investigation to identify additional cases. 
4) Identify whether the source of infection is a major animal health concern. 
5) Initiate control and prevention measures to prevent spread of disease. 
6) Complete and report all information requested via the state electronic 
surveillance system. 
7) As appropriate, use the disease fact sheet (link to fact sheet will be added) to 
educate individuals or groups. 
Diagnosis: 
 Veterinarians who suspect brucellosis should promptly collect blood or bone 
marrow for culture. Liver, spleen, joint fluid and abscesses can also be cultured. 
Serum collected for serologic diagnosis, requires an acute specimen collected as 
soon as possible after onset and a convalescent phase specimen should be 
collected > 14 days after the acute specimen. 
 
 Alert the laboratory to the possibility of Brucella and need for special safety 
procedures. Level A laboratories should consult with state public health 
laboratory director (or designate) prior to or concurrent with testing if Brucella 
species is suspected by the physician. 
 
 Serology and Rapid Testing: The standard laboratory test for Brucella antibody is 
the tube agglutination test, but the simpler rapid slide agglutination test is 
commonly used in commercial laboratories. The rapid slide agglutination test is 
97%--100% sensitive and may be as low as 88% specific. If used in a population 
with a low prevalence of disease, the risk for a false-positive result is high. 
Therefore, diagnostic laboratory testing should be integrated with epidemiologic 
investigation when assessing potential covert biological terrorism events to rule 
out false positive laboratory findings. PCR and ELISA testing may also be 
available. Biopsy specimens: Brucella canis can be identified through direct 
examination of biopsy specimens using direct fluorescent antibody stains. 
 
 Cultures: Brucella canis will grow only in aerobic blood culture bottles after 2-4 
days; followed by isolation as typical colonies on BAP and CHOC within 48 
hours. Presumptively identified as a small, gram-negative coccobacilli that is 
oxidase, catalase and urea positive. Confirmatory identification is made by 







STANDARD CASE INVESTIGATION AND CONTROL METHODS 
Case Investigation 
1) Contact the veterinarian who ordered testing of the case and obtain the 
following information. (This includes medical records.) 
 Using the case report form (link to case report form will be added), identify any 
signs of brucellosis: 
 Record veterinary visits: location, admission and discharge dates. 
 Record onset date (if a reoccurrence – record the earliest onset date). 
 Record the duration of the current illness in weeks. 
 Determine if the onset was acute or insidious. 
 Record symptoms. 
 Record outcomes: recovered or date of death. 
 
2) Review the laboratory tests and enter in the following data: 
 Examine and record any treatment that the case received. 
 Collect owner’s demographic data and contact information (birth date, 
county, sex, race/ethnicity, occupation, address, phone number(s)) 
 Record how many male and female dogs are in the facility. 
 Record how many dogs were screened. 
 Record how many dogs true positive . 
 
3) Interview the owner/manager to determine source and risk factors for canine 
brucellosis (e.g. acquiring new dogs); focus on a 6 month incubation period prior 
to illness onset. 
 
Contact Investigation 
1) Contacts are those dogs with possible exposure to the initial case.  
2) Examine all dogs with direct contact with potential exposures based on potential 
modes of transmission with substances containing Brucella. 
3) Identify persons who may have had direct contact with the animal including any 
kennel workers, veterinarian(s), and/or veterinary staff. Record their name and contact 
information and report this information to the Infectious Disease Epidemiology 















1) Animals that have bred with the case should be tested 
2) Animals that have had direct contact with the case should be tested. This 




1) Canine brucellosis may be transmitted to people. All human contacts will be 
managed by the Infectious Disease Epidemiology and Response staff and/or 
local health department. 
2) Human contacts should be educated on signs and symptoms of the disease and 
conduct a symptom watch/fever check for at least two months post-exposure 
(fact sheet will be attached). 
 
Environmental Measures 
1) Personal protective equipment (PPE) needs to be used when handling placenta 
and fetus from aborted animals. PPE includes: 
 Disposable gloves, 
 Protective Eyewear, 
 Waterproof Shoes, 
 Surgical Mask, and 
 any outer garment that can be disposed or laundered. 
 
2) Clean the area with appropriate cleaning tools. If use of any high-powered 
vacuum or wash be sure to minimize dust so that the organism does not become 
aerosolized. 
 
3)  Disinfect contaminated areas with one of the following: 
 1% sodium hypochlorite, 
 70% ethanol, 
 Iodine/alcohol solution, 




1) Educate high-risk workers (i.e., veterinarians, kennel breeder etc.) about 
the risk of brucellosis and stress methods to reduce occupational exposure 















MANAGING SPECIAL SITUATIONS 
 
A. Outbreak Investigation: 
There are no formal outbreak definitions; however, the investigator may 
consider the possibility of an outbreak when there is an unusual clustering of 
cases in time and/or space. 
1) Notify KDA-DAH (1-785-296-3556) for out breaks in animals.  





 Risks to public health, health care and emergency response personnel are 
not significant. 
Risk Communication Materials: 
 Factsheet for canine brucellosis: Located in KDA-DAH and KDHE Disease 






DATA MANAGEMENT AND REPORTING  
 
A. Organize and collect data. 
 
B. Report data via the Kansas electronic surveillance system, Epi-Trax. 
• All essential data that was collected during the investigation, especially data 
that helps to confirm or classify a case will be entered into Epi-Trax. 
 
